Bass, Berry & Sims will release its 12th Annual Healthcare Fraud & Abuse Review in early February 2024. As a companion to the Review, we will host a complimentary webinar on Tuesday, February 20 from 10:00 a.m.-12:00 p.m. CT, which will provide an overview and discussion of key focus areas covered in the Review.

Continue Reading Register Now | Healthcare Fraud & Abuse Annual Review Webinar

On November 28, the U.S. Court of Appeals for the Second Circuit held that the service-of-process clock for a False Claims Act (FCA) qui tam complaint begins to run when the district court orders the complaint to be served, not when the district court unseals the complaint.

Continue Reading Second Circuit Rejects Insufficient Service-of-Process Argument, Adopts Relator-Friendly Rule

Last month, the Federal Acquisition Regulatory Council proposed new cybersecurity and incident reporting regulations for federal contractors on behalf of the Department of Defense (DoD), the General Services Administration (GSA), and the National Aeronautics and Space Administration (NASA).

Continue Reading Cyber Incident Reporting May Be “Material” for Federal Contractors

A qui tam False Claims Act (FCA) complaint was recently unsealed against Cerebral, a telehealth startup that provides virtual mental-health therapy, in the U.S. District Court for the Northern District of Iowa.  

Continue Reading False Claims Act Case Unsealed Against Cerebral, Showing Continued Scrutiny of Telehealth Prescriptions

Two Massachusetts federal district courts recently addressed—and disagreed about—an important False Claims Act (FCA) issue that has also divided the federal circuit courts: when an alleged FCA violation is based on an underlying violation of the Anti-Kickback Statute (AKS), what kind of causal link must the government or a relator show between the alleged AKS violation and the allegedly false claim for payment? Continue Reading District Courts Wrestle with Causation in Kickback Cases While Circuit Courts Remain Divided

We contributed an article addressing the mounting risks faced by private equity (PE) firms investing in the healthcare industry in the July/August 2023 issue of Mergers & Acquisitions Magazine. In the article, we delved into the complexities of this highly-regulated sector and the heightened attention it receives from government enforcement bodies.

Continue Reading FCA Risk for Private Equity Investment in Healthcare for Mergers & Acquisitions Magazine